References (4)



Evaluation of Pharmaceutical Companies

Andrea Saravalle

University of Urbino

April 8, 2010

The present work has not the task of developing a discussion of the main methods and criteria in evaluating the company, but wants to focus on the evaluation of pharmaceutical companies. from a difference in size of pharmaceutical companies, we will focus on issues such time period, intangible assets, research and development costs, royalty.

Number of Pages in PDF File: 5

Keywords: evaluation, pharmaceutical, valutazione aziendale, patent, intangible

JEL Classification: G30

Open PDF in Browser Download This Paper

Date posted: February 15, 2012  

Suggested Citation

Saravalle, Andrea, Evaluation of Pharmaceutical Companies (April 8, 2010). Available at SSRN: https://ssrn.com/abstract=2004224 or http://dx.doi.org/10.2139/ssrn.2004224

Contact Information

Andrea Saravalle (Contact Author)
University of Urbino ( email )
Via Saffi 2
Urbino, Pesaro-Urbino 61029
Feedback to SSRN

Paper statistics
Abstract Views: 736
Downloads: 185
Download Rank: 129,270
References:  4
Paper comments
No comments have been made on this paper